Dana Pe'er
| Dana Pe'er | |
|---|---|
Dana Pe'er speaking at ISMB 2014.
|
|
| Born | 1971 (age 45–46) |
| Fields |
Biology Computational biology Systems biology |
| Institutions |
Harvard Medical School Columbia University |
| Alma mater | Hebrew University of Jerusalem |
| Thesis | From Gene Expression to Molecular Pathways (2003) |
| Doctoral advisor | Nir Friedman |
| Other academic advisors | George M. Church |
| Notable awards |
|
| Spouse | Itsik Pe'er |
| Children | Inbar, Carmel |
Dana Pe'er is an Associate Professor in the Department of Biological Sciences at Columbia University and regarded as one of the leading researchers in computational systems biology. Pe'er's research focuses on understanding the organization, function and evolution of molecular networks, particularly how genetic variations alter the regulatory network and how these genetic variations can cause cancer.
Pe'er received her bachelor's degree in mathematics in 1995, her master's degree in 1999 and her PhD in computer science in 2003, all from the Hebrew University of Jerusalem. Her PhD work used machine learning and Bayesian networks to automatically infer regulatory relations between genes, using genomics data. Her PhD advisor was Nir Friedman.
She was subsequently a postdoctoral research fellow in the lab of George M. Church in the Department of Genetics at Harvard Medical School, focusing on how genetic variation changes the regulatory network between individuals and how this subsequently manifests in phenotypic diversity.
Pe'er's lab at Columbia University continues her previous research; firstly, developing computational methods to combine diverse sources of high throughput genomics data and secondly, to develop a holistic view of the cell at a systems level.
One particular focus is on developing methods to determine how genetic variation in DNA alters the regulation of gene expression, with a view to applying this knowledge in personalized cancer treatment. For instance, the ability to predict how particular drugs (individually or in combination) will react with tumours would allow drugs to be prescribed on a per-patient basis.
Pe’er currently serves on the editorial board of the journal Cell.
...
Wikipedia